Microbes and the gut-brain axis

Neurogastroenterology and Motility

Volumn 24, Issue 5, 2012, Pages 405-413

  Bercik, P ^a   Collins, S M ^a   Verdu, E F ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROBIOTIC AGENT; PROOPIOMELANOCORTIN;

ABDOMINAL PAIN; BACTEROIDES THETAIOTAOMICRON; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; BRAIN; CAMPYLOBACTER JEJUNI; CENTRAL NERVOUS SYSTEM; CITROBACTER RODENTIUM; COLITIS; COMMENSAL; FIRMICUTES; GUT BRAIN AXIS; HOMEOSTASIS; HUMAN; HYPERALGESIA; INTESTINE; INTESTINE FLORA; INTESTINE MOTILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MEDIAN EMINENCE; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; REVIEW; RUMINOCOCCUS;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; INTESTINES; MICE; PROBIOTICS;

EID: 84859713007     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01906.x     Document Type: Review

References (74)

1. Banks WA. Evidence for a cholecystokinin gut-brain axis with modulation by bombesin. Peptides 1980; 1: 347-51.
2. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12: 453-66.
3. O'Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology 2011; 214: 71-88.
4. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-8.
5. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10: 159-69.
6. Bäckhed F, Ley RE, Sonnenburg JL et al. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-20.
7. Husebye E, Hellstrom PM, Sundler F et al. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: G368-80.
8. Verdu EF, Collins SM. Microbial-gut interactions in health and disease. Irritable bowel syndrome. Best Pract Res Clin Gastroenterol 2004; 18: 315-21.
9. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-8.
10. Dumas ME, Barton RH, Toye A et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in resistant mice. Proc Natl Acad Sci USA 2006; 103: 12511-6.
11. Zoetendal E, Akkermans AD, DeVos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998; 64: 3854-9.
12. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999; 28: 19-25.
13. Martin R, Heilig GH, Zoetendal EG et al. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol 2007; 103: 2638-44.
14. Coppa GV, Bruni S, Morelli L et al. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 2004; 38: S80-3.
15. Lewis S, Cochrane S. Alteration of sulfate and hydrogen metabolism in the human colon by changing intestinal transit rate. Am J Gastroenterol 2007; 102: 624-33.
16. Tannock GW, Munro K, Harmsen HJM et al. Analysis of the fecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000; 66: 2578-88.
17. Zoetendal EG, Akkermans ADL, Vliet WMA et al. The Host Genotype Affects the Bacterial Community in the Human Gastronintestinal Tract. Microb Ecol Health Dis 2001; 13: 129-34.
18. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
19. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
20. McCartney AL, Wenzhi W, Tannock GW. Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl Environ Microbiol 1996; 62: 4608-13.
21. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004; 70: 3575-81.
22. Kleessen B, Schroedl W, Stueck M et al. Microbial and immunological responses relative to high-altitude exposure in mountaineers. Med Sci Sports Exerc 2005; 37: 1313-8.
23. McBurney WT, McCartney A, Apun A et al. Perturbation of the enterobacterial microflora detected by molecular analysis. Microb Ecol Health Dis 1999; 11: 75-9.
24. Löfmark S, Jernberg C, Jansson JK, Edlund C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother 2006; 58: 1160-7.
25. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1: 56-66.
26. De FilippoC, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-6.
27. Maukonen J, Satokari R, Mättö J et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006; 55: 625-33.
28. Mättö J, Maunuksela L, Kajander K et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213-22.
29. Martinez C, Antolin M, Santos J et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol 2008; 103: 643-8.
30. Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006; 44: 3980-8.
31. Bass NM. Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25(Suppl 1): 23-31.
32. Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005; 54: 987-91.
33. Sandler RH, Finegold SM, Bolte ER et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000; 15: 429-35.
34. Posey DJ, Kem DL, Swiezy NB et al. A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry 2004; 161: 2115-7.
35. Mehdi S. Antibiotic-induced psychosis: a link to D-alanine? Med Hypotheses 2010; 75: 676-7.
36. Ledochowski M, Sperner-Unterweger B, Fuchs D. Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report. Dig Dis Sci 1998; 43: 2513-7.
37. Ledochowski M, Widner B, Sperner-Unterweger B et al. Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig Dis Sci 2000; 45: 1255-9.
38. Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav 1998; 65: 63-8.
39. Gaykema RP, Goehler LE, Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav Immun 2004; 18: 238-45.
40. Goehler LE, Park SM, Opitz N et al. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 2008; 22: 354-66.
41. Lyte M, Li W, Opitz N et al. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006; 89: 350-7.
42. Goehler LE, Gaykema RP, Opitz N et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005; 19: 334-44.
43. Bercík P, De GiorgioR, Blennerhassett P et al. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 2002; 123: 1205-15.
44. Bercik P, Verdú EF, Foster JA et al. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol 2009; 296: R587-94.
45. Sudo N, Chida Y, Aiba Y et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558: 263-75.
46. Heijtz RD, Wang S, Anuar F et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108: 3047-52.
47. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-64.
48. Hooper LV, Wong MH, Thelin A et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-4.
49. Bercik P, Denou E, Collins J et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609.
50. Conti LH, Costello DG, Martin LA et al. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41. Pharmacol Biochem Behav 1994; 48: 497-503.
51. Kalinichev M, Bate ST, Coggon SA et al. Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice. Behav Pharmacol 2008; 19: 71-5.
52. Gareau MG, Wine E, Rodrigues DM et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60: 307-17.
53. Li W, Dowd SE, Scurlock B et al. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009; 96: 557-67.
54. Folks DG. The interface of psychiatry and irritable bowel syndrome. Curr Psychiatry Rep 2004; 6: 210-5.
55. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
56. Harter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci 2003; 253: 313-20.
57. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006; 12: 697-707.
58. Walker JR, Ediger JP, Graff LA et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008; 103: 1989-97.
59. Bercik P, Verdu EF, Foster JA et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139: 2102-12. e1.
60. Bercik P, Park AJ, Sinclair D et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011; 23: 1132-9.
61. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008; 43: 164-74.
62. Desbonnet L, Garrett L, Clarke G et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170: 1179-88.
63. Bravo JA, Forsythe P, Chew MV et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011; 108: 16050-5.
64. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541-51.
65. Verdú EF, Bercik P, Verma-Gandhu M et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55: 182-90.
66. Eutamene H, Lamine F, Chabo C et al. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 2007; 137: 1901-7.
67. Ait-Belgnaoui A, Eutamene H, Houdeau E et al. Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats. Neurogastroenterol Motil 2009; 21: 567-73.
68. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010; 22: 1029-35.
69. Kamiya T, Wang L, Forsythe P et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 2006; 55: 191-6.
70. Ma X, Mao YK, Wang B et al. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol 2009; 296: G868-75.
71. Kunze WA, Mao YK, Wang B et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med 2009; 13: 2261-70.
72. Duncker SC, Kamiya T, Wang L et al. Probiotic Lactobacillus reuteri alleviates the response to gastric distension in rats. J Nutr 2011; 141: 1813-8.
73. Duncker SC, Wang L, Hols P, Bienenstock J. The D-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model. Neurogastroenterol Motil 2008; 20: 843-50.
74. Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13: 35-7.